Deutsche Bank AG reaffirmed their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a report issued on Wednesday morning, Marketbeat.com reports. Deutsche Bank AG currently has a GBX 1,610 ($21.71) target price on the stock.

Other equities research analysts have also issued reports about the company. Beaufort Securities upped their price objective on GlaxoSmithKline plc from GBX 1,750 ($23.59) to GBX 2,000 ($26.97) and gave the stock a buy rating in a research note on Thursday, June 1st. Bryan, Garnier & Co restated a buy rating and issued a GBX 1,750 ($23.59) price objective on shares of GlaxoSmithKline plc in a research note on Wednesday, May 31st. Liberum Capital restated a buy rating and issued a GBX 1,900 ($25.62) price objective on shares of GlaxoSmithKline plc in a research note on Wednesday, May 31st. HSBC Holdings plc restated a buy rating and issued a GBX 1,970 ($26.56) price objective on shares of GlaxoSmithKline plc in a research note on Wednesday, May 31st. Finally, Goldman Sachs Group, Inc. (The) restated a buy rating and issued a GBX 1,900 ($25.62) price objective on shares of GlaxoSmithKline plc in a research note on Wednesday, May 31st. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and seven have assigned a buy rating to the company’s stock. GlaxoSmithKline plc presently has an average rating of Hold and a consensus target price of GBX 1,698.52 ($22.90).

GlaxoSmithKline plc (LON GSK) opened at 1474.00 on Wednesday. GlaxoSmithKline plc has a 12-month low of GBX 1,444.00 and a 12-month high of GBX 1,745.56. The stock has a 50 day moving average price of GBX 1,503.38 and a 200-day moving average price of GBX 1,606.97. The company’s market capitalization is GBX 72.05 billion.

TRADEMARK VIOLATION WARNING: “GlaxoSmithKline plc (GSK) Earns Hold Rating from Deutsche Bank AG” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.dailypolitical.com/2017/09/23/glaxosmithkline-plc-gsk-earns-hold-rating-from-deutsche-bank-ag.html.

The firm also recently declared a dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, August 10th will be issued a GBX 19 ($0.26) dividend. This represents a dividend yield of 1.23%. The ex-dividend date is Thursday, August 10th.

In other news, insider Manvinder Singh Banga acquired 2,267 shares of GlaxoSmithKline plc stock in a transaction that occurred on Wednesday, July 26th. The shares were bought at an average cost of GBX 1,599 ($21.56) per share, with a total value of £36,249.33 ($48,873.30). Also, insider Patrick Vallance acquired 861 shares of GlaxoSmithKline plc stock in a transaction that occurred on Friday, July 14th. The stock was purchased at an average cost of GBX 1,618 ($21.81) per share, for a total transaction of £13,930.98 ($18,782.50). In the last ninety days, insiders purchased 3,152 shares of company stock valued at $5,055,023.

GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

Analyst Recommendations for GlaxoSmithKline plc (LON:GSK)

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.